Free Trial

Couchbase (BASE) Financials

Couchbase logo
$18.18 +0.12 (+0.66%)
Closing price 04:00 PM Eastern
Extended Trading
$17.75 -0.43 (-2.36%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Couchbase

Annual Income Statements for Couchbase

This table shows Couchbase's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2025 2024 2023 2022 2021 2020
Period end date 1/31/2025 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020
Net Income / (Loss) Attributable to Common Shareholders
-75 -80 -68 -61 -44 -29
Consolidated Net Income / (Loss)
-75 -80 -68 -58 -40 -29
Net Income / (Loss) Continuing Operations
-75 -80 -68 -58 -40 -29
Total Pre-Tax Income
-73 -79 -67 -57 -39 -28
Total Operating Income
-79 -85 -69 -56 -33 -30
Total Gross Profit
185 158 135 109 92 75
Total Revenue
209 180 155 124 103 83
Operating Revenue
209 180 155 124 103 83
Total Cost of Revenue
25 22 20 15 12 7.80
Operating Cost of Revenue
25 22 20 15 12 7.80
Total Operating Expenses
263 242 204 165 125 105
Selling, General & Admin Expense
51 43 33 24 16 16
Marketing Expense
142 131 111 89 70 58
Research & Development Expense
71 64 58 52 39 32
Impairment Charge
0.00 5.16 0.00 0.00 - -
Restructuring Charge
0.00 0.05 1.66 0.00 0.00 -
Total Other Income / (Expense), net
5.80 5.71 1.86 -0.96 -5.86 1.85
Interest Expense
0.06 0.04 0.10 0.66 6.97 4.66
Other Income / (Expense), net
5.86 5.75 1.96 -0.30 1.11 6.51
Income Tax Expense
1.80 1.36 1.04 1.02 1.04 0.77
Basic Earnings per Share
($1.45) ($1.70) ($1.53) ($2.37) ($7.71) ($5.33)
Weighted Average Basic Shares Outstanding
51.31M 47.18M 44.79M 25.78M 5.72M 5.49M
Diluted Earnings per Share
($1.45) ($1.70) ($1.53) ($2.37) ($7.71) ($5.33)
Weighted Average Diluted Shares Outstanding
51.31M 47.18M 44.79M 25.78M 5.72M 5.49M
Weighted Average Basic & Diluted Shares Outstanding
53.10M 49.26M 45.61M 44.17M - -
Cash Dividends to Common per Share
$0.00 $0.00 $0.00 $0.00 $0.00 -

Quarterly Income Statements for Couchbase

This table shows Couchbase's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Net Income / (Loss) Attributable to Common Shareholders
-16 -18 -20 -21 -21 -16 -21 -22 -17 -17 -15
Consolidated Net Income / (Loss)
-16 -18 -20 -21 -21 -16 -21 -22 -17 -17 -15
Net Income / (Loss) Continuing Operations
-16 -18 -20 -21 -21 -16 -21 -22 -17 -17 -15
Total Pre-Tax Income
-15 -17 -19 -21 -21 -16 -21 -21 -17 -16 -15
Total Operating Income
-16 -19 -21 -23 -23 -18 -22 -23 -19 -17 -15
Total Gross Profit
49 45 45 46 45 41 37 35 36 34 35
Total Revenue
55 52 52 51 50 46 43 41 42 39 40
Operating Revenue
55 52 52 51 50 46 43 41 42 39 40
Total Cost of Revenue
6.26 6.56 6.46 5.68 5.14 5.11 5.91 5.92 5.95 4.88 4.78
Operating Cost of Revenue
6.26 6.56 6.46 5.68 5.14 5.11 5.91 5.92 5.95 4.88 4.78
Total Operating Expenses
64 64 66 68 68 58 59 58 54 50 50
Selling, General & Admin Expense
13 13 13 13 12 11 10 9.63 8.21 8.83 8.43
Marketing Expense
34 34 36 38 34 32 32 33 29 27 27
Research & Development Expense
18 17 17 18 16 16 16 15 15 14 14
Total Other Income / (Expense), net
0.79 1.77 1.71 1.53 1.77 1.30 1.24 1.41 1.91 0.29 0.24
Interest Expense
0.01 0.02 0.03 0.00 - 0.00 0.02 0.03 0.03 0.03 0.03
Other Income / (Expense), net
0.80 1.79 1.74 1.53 1.77 1.30 1.26 1.43 1.94 0.32 0.26
Income Tax Expense
0.55 0.69 0.56 0.00 0.61 0.00 0.00 0.75 0.03 0.38 0.37
Basic Earnings per Share
($0.29) ($0.35) ($0.39) ($0.42) ($0.44) ($0.34) ($0.44) ($0.48) ($0.37) ($0.37) ($0.34)
Weighted Average Basic Shares Outstanding
51.31M 51.83M 50.82M 49.79M 47.18M 47.59M 46.71M 45.84M 44.79M 44.93M 44.65M
Diluted Earnings per Share
($0.29) ($0.35) ($0.39) ($0.42) ($0.44) ($0.34) ($0.44) ($0.48) ($0.37) ($0.37) ($0.34)
Weighted Average Diluted Shares Outstanding
51.31M 51.83M 50.82M 49.79M 47.18M 47.59M 46.71M 45.84M 44.79M 44.93M 44.65M
Weighted Average Basic & Diluted Shares Outstanding
53.10M 52.35M 51.32M 50.31M 49.26M 48.07M 47.07M 46.41M 45.61M 45.17M 44.79M

Annual Cash Flow Statements for Couchbase

This table details how cash moves in and out of Couchbase's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2025 2024 2023 2022 2021 2020
Period end date 1/31/2025 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020
Net Change in Cash & Equivalents
-11 0.91 -55 58 19 9.18
Net Cash From Operating Activities
-16 -27 -41 -42 -39 -22
Net Cash From Continuing Operating Activities
-16 -27 -41 -42 -39 -22
Net Income / (Loss) Continuing Operations
-75 -80 -68 -58 -40 -29
Consolidated Net Income / (Loss)
-75 -80 -68 -58 -40 -29
Depreciation Expense
2.28 2.42 3.17 2.82 2.01 0.71
Amortization Expense
15 15 17 14 11 7.99
Non-Cash Adjustments To Reconcile Net Income
66 55 29 11 4.87 3.73
Changes in Operating Assets and Liabilities, net
-24 -19 -22 -11 -17 -4.93
Net Cash From Investing Activities
-4.85 15 -23 -92 -22 -4.71
Net Cash From Continuing Investing Activities
-4.85 15 -23 -92 -22 -4.71
Purchase of Property, Plant & Equipment
-3.02 -4.71 -5.65 -0.82 -2.82 -4.71
Purchase of Investments
-101 -131 -145 -112 -20 0.00
Sale and/or Maturity of Investments
99 151 127 21 0.90 0.00
Net Cash From Financing Activities
9.94 13 9.71 192 81 36
Net Cash From Continuing Financing Activities
9.94 13 9.71 192 81 36
Issuance of Common Equity
3.52 2.00 4.48 215 0.00 0.00
Other Financing Activities, net
6.42 11 5.22 7.49 2.19 0.98
Effect of Exchange Rate Changes
-0.62 -0.56 -0.40 -0.42 0.16 -0.14
Cash Interest Paid
0.05 0.04 0.10 0.62 5.95 3.85
Cash Income Taxes Paid
1.77 2.47 0.78 0.80 0.87 0.51

Quarterly Cash Flow Statements for Couchbase

This table details how cash moves in and out of Couchbase's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Net Change in Cash & Equivalents
-2.50 -30 11 10 -5.56 5.47 -4.80 5.79 1.67 -7.56 -1.33
Net Cash From Operating Activities
4.36 -17 -4.85 1.56 -6.45 -13 -0.52 -7.18 -10 -15 -7.66
Net Cash From Continuing Operating Activities
4.36 -17 -4.85 1.56 -6.45 -13 -0.52 -7.18 -10 -15 -7.66
Net Income / (Loss) Continuing Operations
-16 -18 -20 -21 -21 -16 -21 -22 -17 -17 -15
Consolidated Net Income / (Loss)
-16 -18 -20 -21 -21 -16 -21 -22 -17 -17 -15
Depreciation Expense
0.76 0.76 0.36 0.40 0.39 0.40 0.75 0.89 0.87 0.84 0.73
Amortization Expense
2.33 4.38 4.18 4.10 1.19 4.50 4.70 4.54 3.97 4.14 4.40
Non-Cash Adjustments To Reconcile Net Income
19 16 16 15 21 12 12 9.22 6.73 7.64 7.64
Changes in Operating Assets and Liabilities, net
-1.96 -20 -5.84 3.21 -8.01 -14 2.57 0.05 -5.15 -11 -5.06
Net Cash From Investing Activities
-7.74 -15 15 3.70 -2.67 15 -6.87 10 10 5.56 5.69
Net Cash From Continuing Investing Activities
-7.74 -15 15 3.70 -2.67 15 -6.87 10 10 5.56 5.69
Purchase of Property, Plant & Equipment
-0.38 -0.58 -1.07 -1.00 -1.29 -1.07 -1.07 -1.29 -1.55 -1.62 -1.68
Purchase of Investments
-25 -38 -18 -19 -41 -26 -56 -7.82 -34 -41 -16
Sale and/or Maturity of Investments
18 23 34 24 39 42 51 19 46 48 23
Net Cash From Financing Activities
1.17 2.84 0.84 5.09 3.58 3.86 2.73 2.76 1.19 1.63 0.75
Net Cash From Continuing Financing Activities
1.17 2.84 0.84 5.09 3.58 3.86 2.73 2.76 1.19 1.63 0.75
Other Financing Activities, net
1.17 1.12 0.84 3.29 3.58 2.70 2.73 1.92 1.19 0.67 0.75
Effect of Exchange Rate Changes
-0.29 -0.12 0.06 -0.26 -0.02 -0.29 -0.15 -0.10 0.46 -0.02 -0.12
Cash Interest Paid
0.02 0.02 0.01 0.00 - - 0.02 0.03 0.03 0.03 0.03
Cash Income Taxes Paid
0.34 0.29 0.55 0.59 1.22 0.84 0.12 0.29 0.16 0.26 0.08

Annual Balance Sheets for Couchbase

This table presents Couchbase's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2025 2024 2023 2022 2021
Period end date 1/31/2025 1/31/2024 1/31/2023 1/31/2022 1/31/2021
Total Assets
261 248 253 277 117
Total Current Assets
228 224 229 263 104
Cash & Equivalents
31 41 40 96 37
Short-Term Investments
117 112 128 110 20
Accounts Receivable
49 45 40 37 36
Prepaid Expenses
15 10 8.23 8.56 2.45
Other Current Assets
17 15 13 12 8.35
Plant, Property, & Equipment, net
7.21 5.33 7.43 4.29 6.51
Total Noncurrent Assets
25 18 16 9.46 7.14
Other Noncurrent Operating Assets
25 18 16 9.46 7.14
Total Liabilities & Shareholders' Equity
261 248 253 277 117
Total Liabilities
133 117 103 94 104
Total Current Liabilities
127 113 95 90 73
Accounts Payable
2.19 4.87 1.41 1.92 2.43
Accrued Expenses
8.44 4.58 6.08 3.23 4.15
Current Deferred Revenue
94 82 72 69 57
Current Employee Benefit Liabilities
21 18 13 16 9.11
Other Current Liabilities
1.36 3.21 3.12 0.00 -
Total Noncurrent Liabilities
5.65 4.83 7.82 3.22 31
Noncurrent Deferred Revenue
2.69 2.75 3.28 2.71 4.54
Other Noncurrent Operating Liabilities
2.96 2.08 4.54 0.51 1.36
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
128 130 150 183 -246
Total Preferred & Common Equity
128 130 150 183 -246
Preferred Stock
0.00 0.00 0.00 0.00 0.00
Total Common Equity
128 130 150 183 -246
Common Stock
693 621 562 525 37
Retained Earnings
-565 -491 -410 -342 -284
Accumulated Other Comprehensive Income / (Loss)
0.12 0.06 -0.81 -0.20 0.00

Quarterly Balance Sheets for Couchbase

This table presents Couchbase's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 10/31/2024 7/31/2024 4/30/2024 10/31/2023 7/31/2023 4/30/2023 10/31/2022 7/31/2022 4/30/2022 10/31/2021
Total Assets
222 236 243 232 244 249 242 265 267 260
Total Current Assets
194 211 218 207 219 226 220 242 245 248
Cash & Equivalents
33 63 52 47 41 46 39 46 48 141
Short-Term Investments
109 94 108 110 124 117 138 146 153 66
Accounts Receivable
29 31 35 30 32 42 23 29 25 23
Prepaid Expenses
11 10 10 7.45 8.03 6.84 7.77 9.66 8.01 8.19
Other Current Assets
13 13 13 13 13 13 12 12 12 9.22
Plant, Property, & Equipment, net
7.00 7.05 6.11 9.63 8.58 8.03 6.73 5.64 4.34 4.98
Total Noncurrent Assets
21 18 18 15 16 16 16 17 17 7.14
Other Noncurrent Operating Assets
21 18 18 15 16 16 16 17 17 7.14
Total Liabilities & Shareholders' Equity
222 236 243 232 244 249 242 265 267 260
Total Liabilities
96 109 114 97 108 109 84 98 93 68
Total Current Liabilities
91 107 110 90 102 102 77 90 85 64
Accounts Payable
4.72 5.03 4.07 3.17 3.16 6.87 3.52 5.58 2.64 3.52
Accrued Expenses
3.98 3.37 3.81 3.40 4.87 4.81 3.31 4.10 2.95 2.53
Current Deferred Revenue
68 82 90 72 80 79 58 67 68 48
Current Employee Benefit Liabilities
12 14 8.94 9.12 11 8.50 9.05 11 8.03 -
Other Current Liabilities
2.15 2.67 3.11 2.98 2.98 3.06 3.04 3.08 2.72 -
Total Noncurrent Liabilities
4.51 2.20 3.96 6.52 6.49 6.75 7.24 7.96 7.92 4.02
Noncurrent Deferred Revenue
0.83 1.03 2.57 3.78 3.22 2.87 2.58 2.47 2.29 2.73
Other Noncurrent Operating Liabilities
3.68 1.17 1.39 2.74 3.27 3.87 4.66 5.49 5.63 1.30
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
127 127 129 135 136 141 158 166 174 191
Total Preferred & Common Equity
127 127 129 135 136 141 158 166 174 191
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
127 127 129 135 136 141 158 166 174 191
Common Stock
676 658 641 605 589 574 553 545 537 520
Retained Earnings
-550 -532 -512 -469 -453 -432 -394 -377 -362 -329
Accumulated Other Comprehensive Income / (Loss)
0.12 0.03 -0.22 -0.11 -0.30 -0.49 -1.38 -1.04 -0.88 -0.03

Annual Metrics And Ratios for Couchbase

This table displays calculated financial ratios and metrics derived from Couchbase's official financial filings.

Metric 2025 2024 2023 2022 2021 2020
Period end date 1/31/2025 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020
Growth Metrics
- - - - - -
Revenue Growth
16.35% 16.28% 25.32% 19.61% 25.16% 0.00%
EBITDA Growth
9.61% -28.87% -19.42% -111.84% -24.55% 0.00%
EBIT Growth
7.61% -16.97% -19.09% -76.92% -34.13% 0.00%
NOPAT Growth
6.96% -21.96% -23.21% -70.07% -9.02% 0.00%
Net Income Growth
6.90% -17.07% -17.63% -45.63% -36.66% 0.00%
EPS Growth
14.71% -11.11% 35.44% 69.26% -44.65% 0.00%
Operating Cash Flow Growth
41.14% 34.70% 0.94% -6.12% -80.07% 0.00%
Free Cash Flow Firm Growth
-8.72% -1.47% -51.82% -639.43% 0.00% 0.00%
Invested Capital Growth
15.75% -28.68% 20.67% -23.48% 0.00% 0.00%
Revenue Q/Q Growth
2.36% 4.93% 4.42% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
6.10% -14.97% -7.82% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
7.38% -5.72% -5.71% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
7.91% -5.09% -9.19% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
7.20% -6.35% -5.19% 0.00% 0.00% 0.00%
EPS Q/Q Growth
9.38% -4.29% -233.04% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
40.58% 12.25% -22.45% 8.61% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
11.02% 0.19% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-28.98% -8.68% 5.81% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - -
Gross Margin
88.08% 87.73% 86.91% 88.04% 88.75% 90.55%
EBITDA Margin
-26.51% -34.12% -30.79% -32.31% -18.24% -18.33%
Operating Margin
-37.55% -46.96% -44.77% -45.54% -32.03% -36.77%
EBIT Margin
-34.75% -43.76% -43.50% -45.78% -30.95% -28.88%
Profit (Net Income) Margin
-35.64% -44.54% -44.24% -47.13% -38.71% -35.45%
Tax Burden Percent
102.47% 101.72% 101.54% 101.77% 102.68% 102.69%
Interest Burden Percent
100.08% 100.05% 100.15% 101.16% 121.80% 119.54%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-57.86% -57.13% -41.08% -59.21% -296.61% 0.00%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-28.64% -31.46% -25.43% -28.71% -27.28% 0.00%
Return on Assets (ROA)
-29.37% -32.02% -25.86% -29.56% -34.12% 0.00%
Return on Common Equity (ROCE)
-57.86% -57.13% -41.08% 19.00% 5,420.43% 0.00%
Return on Equity Simple (ROE_SIMPLE)
-58.50% -61.48% -45.58% -31.78% 16.23% 0.00%
Net Operating Profit after Tax (NOPAT)
-55 -59 -49 -39 -23 -21
NOPAT Margin
-26.29% -32.87% -31.34% -31.88% -22.42% -25.74%
Net Nonoperating Expense Percent (NNEP)
-13.03% -13.05% -10.67% -15.85% -105.52% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
-43.14% -45.37% -32.29% - - -
Cost of Revenue to Revenue
11.92% 12.27% 13.09% 11.96% 11.25% 9.45%
SG&A Expenses to Revenue
24.18% 23.70% 21.57% 19.43% 15.01% 18.86%
R&D to Revenue
33.69% 35.59% 37.31% 41.80% 37.76% 38.38%
Operating Expenses to Revenue
125.63% 134.69% 131.69% 133.57% 120.78% 127.32%
Earnings before Interest and Taxes (EBIT)
-73 -79 -67 -57 -32 -24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-56 -61 -48 -40 -19 -15
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
7.28 9.21 4.45 5.58 0.00 0.00
Price to Tangible Book Value (P/TBV)
7.28 9.21 4.45 5.58 0.00 0.00
Price to Revenue (P/Rev)
4.43 6.68 4.32 8.27 1.63 2.04
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
3.73 5.82 3.23 6.60 3.83 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 1.85 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 1.85 0.00
Financial Leverage
-1.17 -1.15 -1.12 -1.21 -2.37 0.00
Leverage Ratio
1.97 1.78 1.59 2.00 8.69 0.00
Compound Leverage Factor
1.97 1.79 1.59 2.03 10.59 0.00
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 64.92% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 64.92% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 676.13% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% -641.05% 0.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 -1.32 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 1.69 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 -1.32 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 -1.08 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 1.38 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 -1.08 0.00
Altman Z-Score
1.50 3.59 2.00 5.34 -2.12 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 132.09% 1,927.46% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
1.79 1.99 2.42 2.91 1.42 0.00
Quick Ratio
1.54 1.76 2.19 2.69 1.27 0.00
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
-59 -54 -53 -35 -4.74 0.00
Operating Cash Flow to CapEx
-524.11% -570.98% -729.45% -5,076.19% -1,389.78% -461.93%
Free Cash Flow to Firm to Interest Expense
-978.58 -1,255.88 -526.95 -53.44 -0.68 0.00
Operating Cash Flow to Interest Expense
-263.80 -625.42 -407.77 -63.38 -5.62 -4.67
Operating Cash Flow Less CapEx to Interest Expense
-314.13 -734.95 -463.67 -64.62 -6.03 -5.68
Efficiency Ratios
- - - - - -
Asset Turnover
0.82 0.72 0.58 0.63 0.88 0.00
Accounts Receivable Turnover
4.45 4.25 4.05 3.40 2.88 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
33.41 28.23 26.43 22.89 15.88 0.00
Accounts Payable Turnover
7.08 7.04 12.17 6.79 4.78 0.00
Days Sales Outstanding (DSO)
81.98 85.85 90.23 107.24 126.86 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
51.56 51.84 30.00 53.72 76.29 0.00
Cash Conversion Cycle (CCC)
30.42 34.02 60.23 53.52 50.57 0.00
Capital & Investment Metrics
- - - - - -
Invested Capital
-20 -23 -18 -23 -18 0.00
Invested Capital Turnover
-9.80 -8.73 -7.59 -6.00 -11.22 0.00
Increase / (Decrease) in Invested Capital
3.66 -5.17 4.70 -4.32 -18 0.00
Enterprise Value (EV)
781 1,048 500 815 396 0.00
Market Capitalization
929 1,202 668 1,021 168 168
Book Value per Share
$2.44 $2.71 $3.33 $4.20 ($43.09) $0.00
Tangible Book Value per Share
$2.44 $2.71 $3.33 $4.20 ($43.09) $0.00
Total Capital
128 130 150 183 38 0.00
Total Debt
0.00 0.00 0.00 0.00 25 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 25 0.00
Net Debt
-147 -154 -168 -206 -32 0.00
Capital Expenditures (CapEx)
3.02 4.71 5.65 0.82 2.82 4.71
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-46 -42 -34 -33 -26 0.00
Debt-free Net Working Capital (DFNWC)
101 112 135 173 31 0.00
Net Working Capital (NWC)
101 112 135 173 31 0.00
Net Nonoperating Expense (NNE)
20 21 20 19 17 8.02
Net Nonoperating Obligations (NNO)
-147 -154 -168 -206 -32 0.00
Total Depreciation and Amortization (D&A)
17 17 20 17 13 8.70
Debt-free, Cash-free Net Working Capital to Revenue
-22.01% -23.25% -21.82% -26.93% -25.33% 0.00%
Debt-free Net Working Capital to Revenue
48.25% 62.09% 86.89% 139.78% 29.71% 0.00%
Net Working Capital to Revenue
48.25% 62.09% 86.89% 139.78% 29.71% 0.00%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
($1.45) ($1.70) ($1.53) ($2.37) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
51.31M 47.18M 44.79M 25.78M 0.00 0.00
Adjusted Diluted Earnings per Share
($1.45) ($1.70) ($1.53) ($2.37) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
51.31M 47.18M 44.79M 25.78M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
53.10M 49.26M 45.61M 44.17M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-55 -56 -47 -39 -23 -21
Normalized NOPAT Margin
-26.29% -30.85% -30.59% -31.88% -22.42% -25.74%
Pre Tax Income Margin
-34.78% -43.78% -43.57% -46.31% -37.70% -34.53%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-1,213.18 -1,832.21 -666.88 -86.22 -4.59 -5.12
NOPAT to Interest Expense
-917.64 -1,376.18 -480.40 -60.03 -3.32 -4.56
EBIT Less CapEx to Interest Expense
-1,263.52 -1,941.74 -722.78 -87.46 -4.99 -6.13
NOPAT Less CapEx to Interest Expense
-967.98 -1,485.72 -536.30 -61.28 -3.73 -5.57
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% -8.47% 0.00% 0.00%

Quarterly Metrics And Ratios for Couchbase

This table displays calculated financial ratios and metrics derived from Couchbase's official financial filings.

Metric Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
9.65% 12.69% 19.59% 25.20% 20.34% 18.82% 8.41% 17.63% 18.71% 25.09% 33.98%
EBITDA Growth
37.94% -8.52% 2.68% -5.38% -64.07% -0.42% -54.07% -5.91% -41.79% 0.02% 1.42%
EBIT Growth
27.83% -7.39% 6.34% 0.43% -25.74% 0.19% -37.68% -7.96% -28.16% -4.72% -6.43%
NOPAT Growth
29.92% -9.65% 3.75% -0.03% -22.11% -5.73% -43.56% -18.67% -46.05% -7.11% -8.88%
Net Income Growth
27.06% -11.67% 3.66% 4.02% -28.82% 2.53% -34.37% -10.29% -25.52% -4.73% -6.21%
EPS Growth
34.09% -2.94% 11.36% 12.50% -18.92% 8.11% -29.41% -6.67% -116.02% 0.00% 80.68%
Operating Cash Flow Growth
167.57% -32.58% -834.49% 121.71% 36.78% 13.43% 93.22% 16.57% -284.73% 25.46% 52.11%
Free Cash Flow Firm Growth
-38.50% -95.19% -43.90% 63.08% 39.71% -877.43% 3.18% -247.18% 0.00% 128.15% -167.89%
Invested Capital Growth
15.75% 29.01% 2.53% -37.19% -28.68% -11.52% -17.64% 15.32% 20.67% -206.86% 1.76%
Revenue Q/Q Growth
6.38% 0.08% 0.51% 2.47% 9.33% 6.20% 5.23% -1.51% 7.95% -3.10% 14.17%
EBITDA Q/Q Growth
2.98% 16.59% 10.62% -6.19% -69.67% 25.20% 3.21% -39.29% -3.84% -14.77% 33.47%
EBIT Q/Q Growth
13.83% 9.65% 8.10% -0.87% -28.21% 21.20% 2.30% -27.38% -1.78% -8.70% 23.39%
NOPAT Q/Q Growth
17.68% 8.62% 6.62% 0.23% -28.79% 19.79% 2.95% -21.79% -11.51% -8.92% 19.78%
Net Income Q/Q Growth
14.00% 8.76% 5.24% 1.90% -31.66% 21.29% 5.60% -31.67% 0.38% -8.51% 22.51%
EPS Q/Q Growth
17.14% 10.26% 7.14% 4.55% -29.41% 22.73% 8.33% -29.73% 0.00% -8.82% 24.44%
Operating Cash Flow Q/Q Growth
125.79% -248.35% -411.10% 124.17% 49.38% -2,355.30% 92.77% 29.62% 30.69% -92.29% 11.06%
Free Cash Flow Firm Q/Q Growth
25.03% -26.85% -111.22% 31.05% -5.66% 6.49% 45.81% -12.60% -1,462.49% 111.65% -182.38%
Invested Capital Q/Q Growth
-28.98% 48.59% 5.28% -34.13% -8.68% 29.41% -33.33% -25.81% 5.81% 25.54% 4.02%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
88.61% 87.30% 87.47% 88.93% 89.74% 88.84% 86.30% 85.55% 85.70% 87.36% 87.98%
EBITDA Margin
-21.75% -23.85% -28.61% -32.17% -38.43% -24.76% -35.16% -38.22% -28.19% -29.30% -24.74%
Operating Margin
-28.83% -37.26% -40.80% -43.91% -45.11% -38.29% -50.69% -54.96% -44.45% -43.03% -38.28%
EBIT Margin
-27.37% -33.79% -37.42% -40.93% -41.58% -35.46% -47.79% -51.47% -39.80% -42.21% -37.63%
Profit (Net Income) Margin
-28.42% -35.16% -38.56% -40.90% -42.73% -35.48% -47.87% -53.36% -39.92% -43.25% -38.62%
Tax Burden Percent
103.76% 103.96% 102.89% 99.93% 102.76% 100.07% 100.09% 103.55% 100.15% 102.31% 102.48%
Interest Burden Percent
100.09% 100.10% 100.15% 100.00% 100.00% 100.00% 100.09% 100.12% 100.15% 100.16% 100.17%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-57.86% -61.40% -59.92% -58.74% -57.13% -51.40% -50.22% -44.75% -41.08% -37.26% -34.90%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-22.55% -30.43% -31.03% -31.67% -29.90% -25.65% -30.89% -32.08% -23.26% -24.93% -18.63%
Return on Assets (ROA)
-23.42% -31.66% -31.97% -31.65% -30.72% -25.67% -30.94% -33.26% -23.33% -25.55% -19.13%
Return on Common Equity (ROCE)
-57.86% -61.40% -59.92% -58.74% -57.13% -51.40% -50.22% -44.75% -41.08% -37.26% -34.90%
Return on Equity Simple (ROE_SIMPLE)
0.00% -63.45% -62.02% -61.45% 0.00% -55.74% -55.94% -50.04% 0.00% -41.19% -38.68%
Net Operating Profit after Tax (NOPAT)
-11 -13 -15 -16 -16 -12 -15 -16 -13 -12 -11
NOPAT Margin
-20.18% -26.08% -28.56% -30.74% -31.57% -26.80% -35.49% -38.47% -31.12% -30.12% -26.80%
Net Nonoperating Expense Percent (NNEP)
-3.01% -3.14% -3.21% -3.22% -3.47% -2.38% -2.99% -3.35% -1.96% -2.70% -2.24%
Return On Investment Capital (ROIC_SIMPLE)
-8.68% - - - -12.13% - - - -8.62% - -
Cost of Revenue to Revenue
11.39% 12.70% 12.53% 11.07% 10.26% 11.16% 13.70% 14.45% 14.30% 12.64% 12.02%
SG&A Expenses to Revenue
23.32% 24.45% 24.49% 24.52% 23.64% 23.44% 24.24% 23.48% 19.72% 22.90% 21.18%
R&D to Revenue
32.54% 33.87% 33.67% 34.77% 32.92% 34.71% 37.77% 37.52% 36.04% 36.30% 36.04%
Operating Expenses to Revenue
117.43% 124.56% 128.27% 132.84% 134.84% 127.13% 137.00% 140.52% 130.15% 130.39% 126.27%
Earnings before Interest and Taxes (EBIT)
-15 -17 -19 -21 -21 -16 -21 -21 -17 -16 -15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-12 -12 -15 -17 -19 -11 -15 -16 -12 -11 -9.84
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.28 6.51 7.62 9.21 9.21 5.42 5.71 4.97 4.45 3.63 4.08
Price to Tangible Book Value (P/TBV)
7.28 6.51 7.62 9.21 9.21 5.42 5.71 4.97 4.45 3.63 4.08
Price to Revenue (P/Rev)
4.43 4.03 4.86 6.25 6.68 4.27 4.71 4.35 4.32 3.87 4.83
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
3.73 3.34 4.07 5.41 5.82 3.36 3.70 3.34 3.23 2.67 3.46
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.17 -1.14 -1.23 -1.20 -1.15 -1.14 -1.19 -1.16 -1.12 -1.07 -1.14
Leverage Ratio
1.97 1.73 1.83 1.82 1.78 1.62 1.68 1.64 1.59 1.44 1.54
Compound Leverage Factor
1.97 1.74 1.83 1.82 1.78 1.62 1.69 1.64 1.59 1.44 1.54
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.23 2.93 3.25 4.37 4.36 2.83 2.67 2.41 2.66 2.91 3.18
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.79 2.13 1.97 1.99 1.99 2.30 2.16 2.22 2.42 2.85 2.68
Quick Ratio
1.54 1.87 1.75 1.78 1.76 2.07 1.95 2.02 2.19 2.60 2.45
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-15 -20 -15 -7.34 -11 -10 -11 -20 -18 1.30 -11
Operating Cash Flow to CapEx
1,162.13% -2,897.94% -454.55% 156.68% -501.95% -1,195.40% -48.46% -557.53% -656.99% -910.33% -456.47%
Free Cash Flow to Firm to Interest Expense
-1,052.79 -1,156.52 -534.47 0.00 0.00 0.00 -598.41 -795.08 -706.10 49.83 -445.00
Operating Cash Flow to Interest Expense
311.29 -993.82 -167.24 0.00 0.00 0.00 -28.83 -287.24 -408.12 -566.15 -306.20
Operating Cash Flow Less CapEx to Interest Expense
284.50 -1,028.12 -204.03 0.00 0.00 0.00 -88.33 -338.76 -470.24 -628.35 -373.28
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.82 0.90 0.83 0.77 0.72 0.72 0.65 0.62 0.58 0.59 0.50
Accounts Receivable Turnover
4.45 6.94 6.24 4.96 4.25 6.47 5.35 4.82 4.05 6.58 5.71
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
33.41 24.61 25.43 26.92 28.23 20.97 23.11 26.02 26.43 25.31 25.06
Accounts Payable Turnover
7.08 6.04 5.47 3.99 7.04 6.84 5.19 4.53 12.17 5.24 2.72
Days Sales Outstanding (DSO)
81.98 52.63 58.49 73.62 85.85 56.40 68.27 75.77 90.23 55.46 63.89
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
51.56 60.44 66.71 91.38 51.84 53.37 70.36 80.57 30.00 69.70 134.34
Cash Conversion Cycle (CCC)
30.42 -7.82 -8.23 -17.76 34.02 3.03 -2.08 -4.80 60.23 -14.25 -70.45
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-20 -15 -29 -31 -23 -21 -30 -23 -18 -19 -26
Invested Capital Turnover
-9.80 -11.21 -6.66 -7.07 -8.73 -8.47 -5.87 -6.51 -7.59 -11.68 -5.42
Increase / (Decrease) in Invested Capital
3.66 6.20 0.77 -8.44 -5.17 -2.21 -4.54 4.10 4.70 -13 0.46
Enterprise Value (EV)
781 683 809 1,029 1,048 576 609 537 500 396 486
Market Capitalization
929 825 965 1,189 1,202 732 775 701 668 573 679
Book Value per Share
$2.44 $2.47 $2.52 $2.62 $2.71 $2.87 $2.92 $3.09 $3.33 $3.53 $3.73
Tangible Book Value per Share
$2.44 $2.47 $2.52 $2.62 $2.71 $2.87 $2.92 $3.09 $3.33 $3.53 $3.73
Total Capital
128 127 127 129 130 135 136 141 150 158 166
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-147 -142 -156 -160 -154 -157 -166 -164 -168 -177 -192
Capital Expenditures (CapEx)
0.38 0.58 1.07 1.00 1.29 1.07 1.07 1.29 1.55 1.62 1.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-46 -39 -53 -51 -42 -39 -48 -40 -34 -35 -40
Debt-free Net Working Capital (DFNWC)
101 103 104 109 112 117 117 124 135 143 152
Net Working Capital (NWC)
101 103 104 109 112 117 117 124 135 143 152
Net Nonoperating Expense (NNE)
4.53 4.69 5.16 5.22 5.59 3.98 5.34 6.10 3.66 5.06 4.71
Net Nonoperating Obligations (NNO)
-147 -142 -156 -160 -154 -157 -166 -164 -168 -177 -192
Total Depreciation and Amortization (D&A)
3.09 5.13 4.55 4.50 1.58 4.90 5.45 5.43 4.83 4.98 5.13
Debt-free, Cash-free Net Working Capital to Revenue
-22.01% -18.97% -26.44% -27.02% -23.25% -22.96% -29.42% -24.79% -21.82% -23.27% -28.63%
Debt-free Net Working Capital to Revenue
48.25% 50.40% 52.09% 57.13% 62.09% 68.33% 71.48% 76.87% 86.89% 96.28% 108.07%
Net Working Capital to Revenue
48.25% 50.40% 52.09% 57.13% 62.09% 68.33% 71.48% 76.87% 86.89% 96.28% 108.07%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.29) ($0.35) ($0.39) ($0.42) ($0.44) ($0.34) ($0.44) ($0.48) ($0.37) ($0.37) ($0.34)
Adjusted Weighted Average Basic Shares Outstanding
51.31M 51.83M 50.82M 49.79M 47.18M 47.59M 46.71M 45.84M 44.79M 44.93M 44.65M
Adjusted Diluted Earnings per Share
($0.29) ($0.35) ($0.39) ($0.42) ($0.44) ($0.34) ($0.44) ($0.48) ($0.37) ($0.37) ($0.34)
Adjusted Weighted Average Diluted Shares Outstanding
51.31M 51.83M 50.82M 49.79M 47.18M 47.59M 46.71M 45.84M 44.79M 44.93M 44.65M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
53.10M 52.35M 51.32M 50.31M 49.26M 48.07M 47.07M 46.41M 45.61M 45.17M 44.79M
Normalized Net Operating Profit after Tax (NOPAT)
-11 -13 -15 -16 -16 -12 -15 -16 -12 -12 -11
Normalized NOPAT Margin
-20.18% -26.08% -28.56% -30.74% -31.57% -26.80% -35.49% -38.40% -28.32% -30.12% -26.80%
Pre Tax Income Margin
-27.39% -33.82% -37.48% -40.93% -41.58% -35.46% -47.83% -51.53% -39.86% -42.28% -37.69%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-1,073.64 -1,026.12 -665.76 0.00 0.00 0.00 -1,145.22 -844.00 -662.56 -625.96 -598.88
NOPAT to Interest Expense
-791.65 -791.99 -508.06 0.00 0.00 0.00 -850.46 -630.92 -518.06 -446.71 -426.52
EBIT Less CapEx to Interest Expense
-1,100.43 -1,060.41 -702.55 0.00 0.00 0.00 -1,204.72 -895.52 -724.68 -688.15 -665.96
NOPAT Less CapEx to Interest Expense
-818.44 -826.28 -544.85 0.00 0.00 0.00 -909.96 -682.44 -580.18 -508.90 -493.60
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Couchbase's Financials

When does Couchbase's financial year end?

According to the most recent income statement we have on file, Couchbase's fiscal year ends in January. Their fiscal year 2025 ended on January 31, 2025.

How has Couchbase's net income changed over the last 5 years?

Couchbase's net income appears to be on an upward trend, with a most recent value of -$74.65 million in 2025, rising from -$29.26 million in 2020. The previous period was -$80.18 million in 2024. Find out what analysts predict for Couchbase in the coming months.

What is Couchbase's operating income?
Couchbase's total operating income in 2025 was -$78.66 million, based on the following breakdown:
  • Total Gross Profit: $184.51 million
  • Total Operating Expenses: $263.16 million
How has Couchbase revenue changed over the last 5 years?

Over the last 5 years, Couchbase's total revenue changed from $82.52 million in 2020 to $209.47 million in 2025, a change of 153.8%.

How much debt does Couchbase have?

Couchbase's total liabilities were at $132.98 million at the end of 2025, a 13.3% increase from 2024, and a 28.2% increase since 2021.

How much cash does Couchbase have?

In the past 4 years, Couchbase's cash and equivalents has ranged from $30.54 million in 2025 to $95.69 million in 2022, and is currently $30.54 million as of their latest financial filing in 2025.

How has Couchbase's book value per share changed over the last 5 years?

Over the last 5 years, Couchbase's book value per share changed from 0.00 in 2020 to 2.44 in 2025, a change of 243.8%.



This page (NASDAQ:BASE) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners